Seiter Christopher 4
4 · Trevi Therapeutics, Inc. · Filed Jun 5, 2019
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option (right to buy)
2019-06-03+50,000→ 50,000 totalExercise: $10.12Exp: 2029-06-02→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 3, 2019. The 50,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on June 3, 2020 and as to the remaining 75% of the shares in equal monthly installments thereafter through June 3, 2023.